The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of first-line pembrolizumab treatment in individuals with advanced non-small cell lung cancer and poor performance status.
 
Rajwanth Veluswamy
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck; Novocure
Speakers' Bureau - AstraZeneca
Research Funding - Bristol-Myers Squibb (Inst); Onconova Therapeutics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jiayi Ji
No Relationships to Disclose
 
Liangyuan Hu
No Relationships to Disclose
 
Xiaoliang Wang
Employment - Flatiron Health
Stock and Other Ownership Interests - Roche
 
Cardinale B. Smith
Honoraria - AstraZeneca
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Teva
 
Minal Kale
Research Funding - Teva